← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 DELISTED Scorpius Holdings, Inc. SCPX	22	-2	-8%	$12.4M
77	FRLN 77 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	20	-2	-9%	$217M
78	RCOR 78 DELISTED Renovacor, Inc. RCOR	19	+3	+19%	$34.5M
79	79 BioCardia BCDA $13.9M	16	+8	+100%	$5.96M
80	80 Opus Genetics IRD $324M	14	0	0%	$14.5M
81	81 Benitec Biopharma BNTC $286M	12	+6	+100%	$1.02M
82	82 Enlivex Ltd ENLV $4.26M	11	+7	+175%	$3.36M
83	CYAD 83 DELISTED Celyad Oncology SA American Depositary Shares CYAD	7	0	0%	$6.47M
84	KRBP 84 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	7	+7	–	$919K
85	85 Eterna Therapeutics ERNA $2.38M	5	-1	-17%	$332K
86	SCPS 86 DELISTED Scopus BioPharma Inc. Common Stock SCPS	4	+4	–	$639K
87	ACHL 87 DELISTED Achilles Therapeutics ACHL	–	–	–	–
88	88 DELISTED Arcellx ACLX	–	–	–	–
89	89 Artiva Biotherapeutics ARTV $290M	–	–	–	–
90	90 BioRestorative Therapies BRTX $2.11M	–	–	–	–
91	91 Candel Therapeutics CADL $638M	–	–	–	–
92	92 Creative Medical Technology CELZ $5.75M	–	–	–	–
93	93 DELISTED CERo Therapeutics CERO	–	–	–	–
94	94 Calidi Biotherapeutics CLDI $2.17M	–	–	–	–
95	95 Coya Therapeutics COYA $98.1M	–	–	–	–
96	96 Caribou Biosciences CRBU $49.5M	–	–	–	–
97	97 DELISTED CARGO Therapeutics CRGX	–	–	–	–
98	DBTX 98 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
99	99 enGene Therapeutics ENGN $111M	–	–	–	–
100	100 Estrella Immunopharma ESLA $19.5M	–	–	–	–